跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
N-3
首页
药物
N-3
N-3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
US 8084442 B2
申请人: KURIMURA MUNEAKI
优先权: 2005
CN
US
8 件公开
N-arylsulfonyl-3-aminoalkoxyindoles
US 2006173193 A1
申请人: RAMAKRISHNA VENKATA S N
优先权: 2002
CN
US
5 件公开
PRODRUG DERIVATIVES OF (E)-N-METHYL-N-((3-METHYLBENZOFURAN-2-YL)METHYL)-3-(7-OXO-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-3-YL)ACRYLAMIDE
US 2014051666 A1
申请人: AFFINIUM PHARM INC
优先权: 2013
CN
US
5 件公开
MIXTURES AND USES OF (2E)-3-(1,3-BENZODIOXOL-5-YL)-N-PHENYL-N-(TETRAHYDRO-3-FURANYL)-2-PROPENAMIDE
EP 4554572 A2
申请人: SYMRISE AG
优先权: 2022
CN
EP
US
WO
4 件公开
Process for the production of N-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-N-ethylacetamide (zaleplon)
US 6884888 B2
申请人: TEVA GYOGYSZERGYAR RESZVENYTAR
优先权: 2001
CN
US
4 件公开
Administration regime for N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2- ylcarbonylamino]ethoxy}benzamide
US 8883199 B2
申请人: KLOOS IOANA
优先权: 2012
CN
US
4 件公开
Preparation of (S)-(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl) propylamine using optically active methylhydroxylaminopropanol compound as an intermediate
US 8148549 B2
申请人: CHEN BO-FONG
优先权: 2009
US
4 件公开
Mixtures containing (E)-3-benzo[1,3]dioxol-5-yl-N,N-diphenyl-2-propenamide
US 10980727 B2
申请人: SYMRISE AG
优先权: 2016
CN
EP
US
3 件公开
PROCESS FOR PREPARATION OF SUBSTITUTED N-(2-CHLOROETHYL)-N´-HYDROXY-3-PHENOXYPYRIDAZINE-3- CARBOXAMIDINES AND SUBSTITUTED 3-(3-PHENOXYPYRIDAZIN-4-YL)-5,6-DIHYDRO-4H-1,2,4-OXADIAZINES
EP 4801893 A1
申请人: BAYER AG
优先权: 2023
CN
EP
WO
3 件公开
Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
US 7037928 B2
申请人: PLIVA PHARM & CHEM WORKS
优先权: 2000
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈